SCHEMBL5459702

SCHEMBL5459702

CC(C)c1ccc(NC(=O)Nc2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.63
ALDH1A1 P00352 5/20 0.63
HTT P42858 4/20 0.63
MAPK1 P28482 3/20 0.63
NPC1 O15118 2/20 0.63
L3MBTL1 Q9Y468 2/20 0.63
RAB9A P51151 1/20 0.63
NAMPT P43490 1/20 0.61
SMN1; SMN2 Q16637 7/20 0.58
TSHR P16473 2/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
PANK3 Q9H999 5/20 0.58
TP53 P04637 2/20 0.57
THRB P10828 1/20 0.57
LMNA P02545 4/20 0.54
GPR119 Q8TDV5 3/20 0.51
ESR2 Q92731 1/20 0.50
KDM4E B2RXH2 1/20 0.50
GAA P10253 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10223333 0.90 MAPT (0.64) MAPTALDH1A1HTTMAPK1NPC1
SCHEMBL5463400 0.89 NAMPT (0.57) MAPTALDH1A1HTTMAPK1NPC1
SCHEMBL5460938 0.86 NAMPT (0.64) MAPTALDH1A1HTTMAPK1NPC1
SCHEMBL13853617 0.85 NAMPT (0.66) MAPTALDH1A1HTTNPC1NAMPT
SCHEMBL7332428 0.84 NAMPT (0.65) MAPTALDH1A1HTTNPC1NAMPT
SCHEMBL5458134 0.84 NAMPT (0.61) MAPTALDH1A1HTTNPC1NAMPT
SCHEMBL5473427 0.84 NAMPT (0.61) MAPTALDH1A1HTTMAPK1NPC1
SCHEMBL3256196 0.83 NAMPT (0.69) MAPTALDH1A1HTTNPC1NAMPT
SCHEMBL29037711 0.83 NAMPT (0.69) MAPTALDH1A1HTTNPC1NAMPT
SCHEMBL5460668 0.83 PANK3 (0.65) MAPTALDH1A1HTTMAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 MAPT 758/4885ALDH1A1 731/4885HTT 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.